Since the submission and during review of this manuscript, a new report has highlighted that missense mutations in Menin that hinder the binding of MI to Menin, cause emergence and growth of AML resistant to MI treatment leading to relapse [62]. The gene discussed is MEN1; the disease is acute myeloid leukemia.